Clinical Trial Update: Extended-release of Octreotide (LF-PB) for the Treatment of Seroma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating extended-release octreotide (LF-PB) for treatment of seroma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seroma

Drugs mentioned

• Octreotide extended-release (LF-PB) (octreotide)

Snippet

Sponsor: Chemi S.p.A. | Conditions: Seroma | Phase 2 | Status: COMPLETED